🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase 3 study is designed to demonstrate the safety and immunogenicity...
Status
Completed
Location
37 Alabama Clinical Therapeutics LLC 52 Medical Park East Drive Suite 203
Start Date
2009-11
Trial ID
NCT01000311
Treatments Being Tested
To evaluate the immune response and the safety of a primary series schedule...
Status
Completed
Location
Multiple Locations
Start Date
2013-05-01
Trial ID
NCT01839188
Treatments Being Tested
This is a follow-up of the primary series vaccination schedule in Study A3L...
Status
Completed
Location
Multiple Locations
Start Date
2011-09
Trial ID
NCT01444781
The purpose of this study is to evaluate safety and immunogenicity of Pedia...
Status
Completed
Location
Multiple Locations
Start Date
2006-07
Trial ID
NCT00343421
Treatments Being Tested
The aims of this trial are to demonstrate the consistency of three manufact...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-01-06
Trial ID
NCT00148941
Treatments Being Tested
To demonstrate that the immune response to hepatitis B antigen of the DTaP-...
Status
Completed
Location
Multiple Locations
Start Date
2006-07
Trial ID
NCT00315055
Treatments Being Tested
This is a study to evaluate the immune response and safety of GSK Biologica...
Status
Completed
Location
GSK Investigational Site
Start Date
2003-11-11
Trial ID
NCT00197236
The present clinical study will assess the immunogenicity and reactogenicit...
Status
Completed
Location
Multiple Locations
Start Date
2006-04
Trial ID
NCT00319852
Treatments Being Tested
This multicentre, parallel group, block randomised clinical trial aims to i...
Status
Completed
Location
Centre for Clinical Vaccinology and Tropical Medicine
Start Date
2015-08
Trial ID
NCT02482636
Currently, there is no 5-component acellular pertussis vaccine licensed for...
Status
Completed
Location
Multiple Locations
Start Date
2007-04
Trial ID
NCT00467519